Shilpa M. Hattangadi, MD, is a pediatric hematologist-oncologist and physician-scientist. She currently serves as an Attending Physician and Program Director at the National Institutes of Health, leading efforts within NIDDK to shape and support national research programs in hematology and related biomedical science. Her clinical work centers on pediatric nonmalignant hematology, complex and treatment-resistant anemia care, and inherited bone marrow failure syndromes. Her research interests focus on hematopoiesis and red blood cell development, epigenetics and chromatin regulation in blood formation, and translational therapeutics including systematic drug repurposing to accelerate access to new treatments. Dr. Hattangadi is a recipient of the Hyundai Impact Award and is recognized for NIH leadership through the development of innovative funding initiatives advancing nonmalignant hematology. She earned her MD from Duke University School of Medicine, completed a pediatrics residency at The Johns Hopkins Hospital, and trained in pediatric hematology/oncology at Dana-Farber Cancer Institute/Boston Children’s Hospital.
Attending Physician
Medical School
1995 – 1999
Residency
1999 – 2002
Fellowship
2002 – 2005